T Cells

Graphic image of a pen signing a signature while two strangelooking business people cheer

Ipsen taps Biomunex's MAITs to treat solid tumors in $610M bet

The biobuck bet has landed the French drugmaker exclusive global rights to a preclinical Biomunex prospect that engages a subset of cytotoxic T cells.

Nick Paul Taylor Dec 3, 2024 6:00am

Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

Nov 13, 2024 2:57pm

Graphic of two hands shaking under a red and purple light

Gilead bets $1.5B-plus on Merus' trispecifc T-cell engagers

Mar 6, 2024 10:02am

Using cancer's 'superpower' to boost T-cell therapies in mice

Feb 12, 2024 3:30pm

An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

Elicio vaccine boosts T-cell therapy response to tumors in mice

Jan 29, 2024 10:53am

DNA gene therapy gene editing helix CRISPR

Chromosome loss from CRISPR-Cas9 stopped by swapping steps

Oct 9, 2023 7:40am